When colon-derived phenolic catabolites are included with flavanone glucuronide and sulfate metabolites, orange juice (poly)phenols are much-more bioavailable than previously envisaged. In vitro and ex vivo studies on mechanisms underlying the potential protective effects of orange juice consumption should use in vivo metabolites and catabolites detected in this investigation at physiologic concentrations. The trial was registered at BioMed Central Ltd (www.controlledtrials.com) as ISRCTN04271658.

Recent studies have documented that a diverse assemblage of bacteria is present on the feathers of wild birds and that uropygial oil affects these bacteria in diverse ways. These findings suggest that birds may regulate the microbial flora on their feathers. Birds may directly inhibit the growth of harmful microbes or promote the growth of other harmless microbes that competitively exclude them. If keratinolytic (i.e., feather-degrading) bacteria degrade colored feathers, then plumage coloration could reveal the ability of individual birds to regulate microbial flora. We used field- and lab-based methods to test whether male eastern bluebirds (Sialia sialis) with brighter blue structural plumage coloration were better able to regulate their microbial flora than duller males. When we sampled bluebirds in the field, individuals with brighter color had higher bacterial loads than duller individuals. In the lab, we tested whether bacteria could directly alter feather color. We found that keratinolytic bacteria increased the brightness and purity, decreased the ultraviolet chroma, and did not affect the hue of structural color. This change in spectral properties of feathers may occur through degradation of the cortex and spongy layer of structurally colored barbs. These data suggest that bacteria can alter structural plumage color through degradation.

The study provides novel information on the potential involvement of the colonic microbiota in the overall bioavailability of orange juice (poly)phenols through the production of phenylpropionic acids and subsequent hepatic conversions that lead to hippuric acid and its hydroxylated analogues.

A healthy diet involves eating fruit and vegetables on a daily basis, the benefits of which are in part linked to the ingestion of bioactive compounds including polyphenols. As a convenient means of delivering additional polyphenols to the diet, a polyphenol-rich (P-R) juice drink was prepared and the bioavailability of its diverse spectrum of constituents investigated. Ten human volunteers followed a low-flavonoid diet for 2 days before drinking 350 mL of the P-R beverage. Plasma and urine were collected for 24 h and analyzed by HPLC-PDA-MS. The plasma pharmacokinetics and recoveries of urinary metabolites of flavan-3-ols, flavanones, dihydrochalcones and 5-O-caffeoylquinic acid, both in terms of their identity and quantity, were, in most instances, not markedly different to those reported in other feeding studies with green tea, orange juice, apple cider and coffee. This indicates that the combination of polyphenolic compounds in the P-R beverage are absorbed and excreted to a similar extent whether fed individually or together in a single beverage. It is concluded that the P-R beverage can deliver the intended blend of bioavailable polyphenols, which would normally require consumption of several different plant-derived foods.

Epstein-Barr virus (EBV) infection plays a major role in the pathogenesis of posttransplant lymphoproliferative disorder (PTLD). Quantitative oropharyngeal EBV shedding measured by a DNA-DNA dot blot assay and the genotype of isolates determined by a polymerase chain reaction assay were studied in 23 renal and 23 cardiac transplant recipients followed over the first posttransplant year. Five patients developed PTLD and two additional PTLD renal transplant recipients were studied from the time of diagnosis. Significantly higher levels of EBV were observed in primary versus reactivation infection (P < .04) when sequential courses of antilymphocyte globulins or > 4 g of methylprednisolone were used in the first 6 months after transplant and in patients with versus those without PTLD (P < .04), although the former group had a high incidence of primary infection. Patients with the highest EBV shedding had the poorest serologic responses. All PTLD patients shed EBV-1, which was also shed by patients without PTLD.